ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
|Slideshows|August 6, 2020
- Vol 65 No 08
- Volume 64
- Issue 08
Terminology for ob/gyns to use when treating transgender patients
Transgender and nonbinary people face disproportionate rates of stigma and discrimination in seeking healthcare—and may encounter additional unique barriers in attaining gynecologic and reproductive care.
Advertisement
In this month's issue of Contemporary OB/GYN, Drs. Crissman and Stroumsa authored a feature story that discussed the needs of transgender and nonbinary people.
Excerpt:
"Ob/gyns have the opportunity to play a significant role in improving access to quality gynecologic and reproductive care for transgender and nonbinary people. This can be done with relative ease, with compassion, gender-inclusive practices, sensitivity to patients’ lived experiences, and a modest expansion of the traditional baseline knowledge regarding hormones and gender-affirming medical interventions."
The following are terms and definitions Drs. Crissman and Stroumsa provided to help ob/gyns use correct and appropriate terminology when caring for patients.
Articles in this issue
about 6 years ago
Was loss of ovary in this pediatric case avoidable?about 6 years ago
August issue roundup: Vol 65 No 08about 6 years ago
Resources for transgender careabout 6 years ago
Overcoming racism and unconscious bias in ob/gynabout 6 years ago
Gynecologic care considerations for transmasculine peopleabout 6 years ago
AUGS: Vaginal Energy-Based Devicesabout 6 years ago
Addressing inequalities in women's health researchabout 6 years ago
Chairman's message: Implicit bias and racismabout 6 years ago
Ensuring racial justice and health equity in ob/gynAdvertisement
Related to this article
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
In September, the FDA accepted an extended duration sNDA for the IUD with a decision expected in Q2 2027.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause
2
Multi-society framework ties cardiovascular risk to female life stages
3
Safety Monitoring and Dosing for NK3 Antagonists in Menopause VMS
4
Mind, Body, & the Pause: Menopause, brain fog, and screening gaps, with Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG
5